From Smoking to Cancers: Novel Targets to Neuronal Nicotinic Acetylcholine Receptors
Author Information
Author(s): Lee Chia-Hwa, Wu Chih-Hsiung, Ho Yuan-Soon
Primary Institution: Taipei Medical University
Hypothesis
Understanding the role of nicotinic acetylcholine receptors (nAChRs) in cancer development and their potential as therapeutic targets.
Conclusion
Nicotine and tobacco-specific nitrosamines promote cancer development through their interaction with nicotinic acetylcholine receptors.
Supporting Evidence
- Cigarette smoking is a major cause of cancer mortality.
- Nicotine and nitrosamines can stimulate cancer cell proliferation.
- nAChRs are important therapeutic targets for various diseases.
Takeaway
Smoking can cause cancer because it has chemicals that interact with special receptors in our body, which can make cells grow uncontrollably.
Methodology
The study reviews various research findings on the effects of nicotine and nitrosamines on nAChRs and their role in cancer.
Limitations
The study primarily focuses on the mechanisms and does not provide new experimental data.
Participant Demographics
The study includes data from 1,989 lung cancer patients and 2,625 control subjects from six central European countries.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website